Skip navigation

Practical Strategies for Evidence-Based Risk Sharing and Performance Measurement Between Manufacturers and Payers

October 3-4, 2018
  • Philadelphia, PA

Life sciences manufacturers are facing heightened pressure from the government and other entities to lower the cost of drugs while improving patient outcomes. In an effort to shift from price-per-volume to high-value care, manufacturers are being tasked with bringing treatments to market with outcomes-based, risk-sharing agreements.

CBI’s 3rd Annual Outcomes-Based Contracting Summit delivers key insights into the process of outlining, structuring and negotiating successful performance and value-based contracts. This conference also provides an excellent platform for manufacturers, payers and providers to discuss the challenges and successes regarding government price reporting, value optimization and price alignment with health outcomes data.

Solutions-Oriented Sessions Focused On:

  • Assessing the future impact of CMS’ newly proposed value-based care models on manufacturer responsibilities
  • Gaining an understanding of the risk-sharing challenges from the payer’s perspective
  • Identifying key considerations for partnering with ACOs
  • Mitigating risks associated with the provision and coordination of patient support services
  • Addressing performance-measuring questions via complex patient care scenarios
  • Discussing the challenges and rewards of co-developing drugs and diagnostics for enhanced outcomes

Outcomes-Based Contracting Summit

Practical Strategies for Evidence-Based Risk Sharing and Performance Measurement Between Manufacturers and Payers

Life sciences manufacturers are facing heightened pressure from the government and other entities to lower the cost of drugs while improving patient outcomes. In an effort to shift from price-per-volume to high-value care, manufacturers are being tasked with bringing treatments to market with outcomes-based, risk-sharing agreements.

CBI’s 3rd Annual Outcomes-Based Contracting Summit delivers key insights into the process of outlining, structuring and negotiating successful performance and value-based contracts. This conference also provides an excellent platform for manufacturers, payers and providers to discuss the challenges and successes regarding government price reporting, value optimization and price alignment with health outcomes data.

Solutions-Oriented Sessions Focused On:

  • Assessing the future impact of CMS’ newly proposed value-based care models on manufacturer responsibilities
  • Gaining an understanding of the risk-sharing challenges from the payer’s perspective
  • Identifying key considerations for partnering with ACOs
  • Mitigating risks associated with the provision and coordination of patient support services
  • Addressing performance-measuring questions via complex patient care scenarios
  • Discussing the challenges and rewards of co-developing drugs and diagnostics for enhanced outcomes